SmallCaps Podcast

Chimeric Therapeutics (ASX: CHM) managing director and chief executive office Jennifer Chow joins Small Caps to discuss the successful results of a new brain cancer (glioblastoma) treatment trial.

The phase 1A trial achieved a 55% disease control rate (DCR) in patients treated with its CLTX CAR T solution, well above historical disease control rates.

Under that trial two patients exceeded a survival period of 14 months, while three patients remained alive and in follow up.

This is in direct comparison to survival expectations of around 7 months for patients after first line therapy.

Data obtained from the dose escalation program has provided highly encouraging results, particularly with a number of participants considered very late stage cancer patients.

Chimeric is now opened enrolment for the phase 1B stage of the trials.

Articles:
https://smallcaps.com.au/chimeric-therapeutics-positive-interim-data-cltx-car-t-brain-cancer-trial/
https://smallcaps.com.au/chimeric-therapeutics-chm-0201-cell-study-treatments-acute-myeloid-leukaemia/
https://smallcaps.com.au/chimeric-therapeutics-completes-further-dosing-brain-cancer-clinical-trial/
https://smallcaps.com.au/imugene-worldwide-licence-cd19-cell-therapy-treat-relapsed-cancer-patients/

For more information on Chimeric Therapeutics:
https://smallcaps.com.au/stocks/asx-chm/

See omnystudio.com/listener for privacy information.

Wide Open Agriculture’s (ASX: WOA) chief executive officer Jay Albany joins Small Caps to discuss the company’s recent acquisition of leading European lupin protein producer Prolupin.

The acquisition provides Wide Open with immediate commercial production capacity in a dynamic environment for the development of plant-based protein products.

Wide Open is already eyeing off the strategic opportunity to take advantage of Propulin’s state-of-the-art manufacturing facility to add European production of the company’s lead Buntine Protein product.

The company is preparing to upgrade the Prolupin facility to lift production to 1,000 tonnes per annum.

The company is also planning to leverage Prolupin’s established business to business network in the European plant-based dairy market and its own significant pipeline to supply large global ingredient and food manufacturing companies.

Article:
https://smallcaps.com.au/wide-open-agriculture-acquire-prolupin-worlds-largest-lupin-protein-producer/

For more information on Wide Open Agriculture:
https://smallcaps.com.au/stocks/asx-woa/

See omnystudio.com/listener for privacy information.

Lithium Universe (ASX: LU7) chief executive officer Alex Hanly joins Small Caps to discuss the company’s recent successful ASX re-listing, its on-the-ground activities in Canada and plans to develop a multi-purpose battery-grade lithium carbonate refinery.

The company attracted significant interest when it re-listed on the ASX in mid-August with a new team and a new focus after completing an over-subscribed $4.5 million initial public offer (IPO).

Within weeks of its ASX relisting, members of Lithium Universe’s “dream team” of battery metal and Canadian exploration experts were able to hit the ground running at the company’s highly prospective Apollo project in the “red hot” James Bay region of Quebec.

With a number of clear targets in a project area surrounded by significant lithium discoveries, the company has added artificial intelligence (AI) technology to its arsenal as it assesses future drilling locations in the large 240 sq km land holding.

With a clear strategy to move quickly from explorer to developer, Lithium Universe has now signed on leading international firm Hatch to undertake an engineering study for the design of the battery-grade lithium carbonate refinery, which will form part of the company’s Québec Lithium Processing Hub (QLPH) strategy.

Article:
https://smallcaps.com.au/lithium-universe-development-plans-take-off-hatch-appointment/
https://smallcaps.com.au/lithium-universe-primero-group-quebec-processing-hub-concentrator-study/
https://smallcaps.com.au/lithium-universe-appoints-key-executives-develop-quebec-processing-hub/
https://smallcaps.com.au/lithium-universe-plans-lithium-processing-hub-canada/

For more information on Lithium Universe:
https://smallcaps.com.au/stocks/asx-lu7/

See omnystudio.com/listener for privacy information.

CGN Resources (ASX: CGR) managing director Stan Wholley joins Small Caps to discuss the company’s successful $10 million initial public offer (IPO) and exploration plans for its large Webb iron oxide, copper-gold (IOCG) project in Western Australia’s highly prospective West Arunta region.

With an initial minimum raising target of $8 million at $0.20 a share, CGN was swamped by investors and eventually attracted $10 million in offers.

The company is now preparing to list on the ASX around the 12th October 2023 and looking to undertake a significant exploration campaign at Webb.

This includes a 1,200 metre diamond core drilling campaign at the Tantor and Surus targets ahead of expanded and more detailed exploration in the new year.

CGN holds an 86% interest in seven granted and one pending exploration licences across 948 square kilometres of tenure at Webb.

The company has already identified the significant copper potential of the IOCG target and opportunistically target magmatic nickel sulphides, rare earth elements and diamondiferous kimberlites within the Webb project tenements.

Article:
https://smallcaps.com.au/cgn-resources-ipo-advance-webb-project/

For more information on CGN Resources:
https://smallcaps.com.au/stocks/asx-cgr/

See omnystudio.com/listener for privacy information.

Pioneer Lithium (ASX: PLN) chief executive officer Clinton Booth joins Small Caps to discuss the company's ASX listing following a $5 million initial public offering.

The funds will be used to support the company’s hunt for high-value battery metals discoveries in Canada. Led by a highly-regarded and experienced team, Pioneer Lithium holds sizeable lithium prospective tenements in Ontario and Quebec.

The company’s initial exploration focus will be on the Root Lake project in the Red Lake lithium district of Ontario where previous exploration has already confirmed the presence of high-grade spodumene mineralisation.

The Ontario tenements are well located between two known lithium deposits held by Green Technology Metals (ASX: GT1) – the Root Bay deposit which is estimated to contain 8.1 million tonnes of mineralisation at 1.32% lithium oxide and the McCombe deposit with has an estimated 4.5 million tonnes at 1.01% lithium oxide.

The company aims to begin its maiden drilling program at Root Lake in October. Leading the company’s growth plans is a team of industry veterans with a record of success in finding lithium in Canada and who have completed a combined 50,000m plus of drilling in the nation.

Executive chairman Robert Martin brings more than 25 years of experience to his role including being a key leader at Critical Resources (ASX: CRR) with a market cap of around $80 million and Battery Age Minerals (ASX: BM8), which has a $30 million market cap.

Mr Booth’s background includes over 20 years of experience in the mining and energy sectors, including experience in lithium exploration, development and operations across hard rock and brine deposits.

He has previously held senior positions at Fortescue Future Industries, Galaxy Resources (now Allkem (ASX: AKE)) and Sundance Resources.

Article:
https://smallcaps.com.au/pioneer-lithium-launches-ipo-fund-exploration-plans-canada/

For more information on Pioneer Lithium:
https://smallcaps.com.au/stocks/asx-pln/

See omnystudio.com/listener for privacy information.

Astral Resources (ASX: AAR) managing director Marc Ducler joins Small Caps to discuss the positive results obtained into a study into the potential development of the 100%-owned Mandilla gold project in Western Australia.

One of the largest undeveloped free-milling open pit gold development projects in the rich Kalgoorlie region, Mandilla is forecast to produce around 100,000 ounces per annum at an average feed grade of 1.30 grams per tonnes gold over an initial 7.4-year period.

The Astral board is now assessing a move to the pre-feasibility phase for the project after the scoping study results highlighted commercial viability of a stand-alone gold mining operation.

Key financial outcomes from the scoping study include free cash flow of $740 million and a net present value (8%) of $442 million.

Astral believes there is significant growth opportunities at Mandilla and continues to advance exploration and resource definition efforts as well as at the company’s nearby Feysville gold project.

Article:
https://smallcaps.com.au/astral-resources-releases-positive-scoping-study-mandilla-gold-project/

For more information on Astral Resources:
https://smallcaps.com.au/stocks/asx-aar/

See omnystudio.com/listener for privacy information.

92 Energy (ASX: 92E) chief executive officer Siobhan Lancaster joins Small Caps to discuss the company’s timely discovery of a potential new zone of mineralisation at its Gemini uranium find in Canada’s world-class Athabasca Basin.

The new parallel structure was identified in a recent follow-up campaign to the September 2021 Gemini uranium discovery.

The hole returned uranium mineralisation and key uranium pathfinders with intense alteration, making it ripe for follow-up drilling and assay results to further confirm the potential of the new find are expected imminently.

92 Energy’s uranium exploration is targeting high-grade unconformity-associated uranium in the Athabasca Basin, home of the richest uranium fields in the world.

The uncovering of the new structure has highlighted the potential for 92 Energy to encounter other new zones along the Gemini trend, which remains largely untested.

To date there has been very limited drilling at the newly discovered parallel structure, with around 600m of virtually untested strike length available to be tested in the future.

Uranium prices have been particularly strong recently, surging to US$69 per pound.

Article:
https://smallcaps.com.au/92-energy-hits-potential-new-uranium-zone-gemini/

For more information on 92 Energy:
https://smallcaps.com.au/stocks/asx-92e/

See omnystudio.com/listener for privacy information.

PharmAust (ASX: PAA) chief executive officer Michael Thurn joins Small Caps to discuss his appointment to the company and recent trial developments.

The company recently released interim analysis of data from a Phase 1 clinical trial of its lead drug candidate monepantel (MPL) to treat motor neurone disease/amyotrophic lateral sclerosis (MND/ALS).

Results from an interim analysis of the trial indicated that neurofilament light chain (Nfl) protein concentrations in the plasma of participants in its Phase 1 clinical trial do not increase following MPL treatment – a positive sign.

PharmAust hopes that MPL could eventually receive orphan drug designation by the Therapeutics Goods Administration (TGA) and US Food and Drug Administration (FDA) for motor neurone disease, which affects over 350,000 people globally and kills more than 100,000 people yearly.

Article:
https://smallcaps.com.au/pharmaust-names-highly-experienced-biotech-specialist-chief-executive-officer/
https://smallcaps.com.au/pharmaust-interim-phase-1-data-mpl-inhibit-motor-neurone-disease/

For more information on PharmAust:
https://smallcaps.com.au/stocks/asx-paa/ 

See omnystudio.com/listener for privacy information.

Piedmont Lithium (NASDAQ: PLL) president and chief executive officer Keith Phillips joins Small Caps to discuss the latest progress made at the company’s North American Lithium (NAL) operation in Canada.

Articles:
https://smallcaps.com.au/ghana-sovereign-wealth-fund-backs-atlantic-lithium-piedmont-mine/
https://smallcaps.com.au/maiden-cash-flow-sayona-piedmont-canada-lithium-alliance/
https://smallcaps.com.au/piedmont-lithium-banks-pre-payment-inaugural-sale-nal-concentrate/

For more information on Piedmont Lithium:
https://smallcaps.com.au/stocks/asx-pll/

See omnystudio.com/listener for privacy information.

Elevate Uranium (ASX: EL8) managing director and chief executive officer Murray Hill joins Small Caps to discuss the expansion of the company’s drilling campaign at the Koppies uranium project in Namibia.

The company recently added an additional rig to its Koppies program, with a three rig, reverse circulation program targeting the finalisation of an interim resource for Koppies 3 during October 2023.

This will be followed by further drilling to test areas located outside of the interim resource zone, with results aimed at expanding the current JORC resource of 20.3 million pounds of uranium identified at Koppies 1 and 2.

The company is also preparing to follow up previous exploration success at Capri where Elevate has already identified multiple additional exploration targets.

The company is working to obtain new land access agreements prior to bringing a rig in for the exploration campaign.

Article:
https://smallcaps.com.au/elevate-uranium-increases-drilling-operation-koppies-project-namibia/

For more information on Elevate Uranium:
https://smallcaps.com.au/stocks/asx-el8/

See omnystudio.com/listener for privacy information.